Effective October 1, 2018, Ashland adopted accounting guidance outlining a single comprehensive five step model for entities to use in accounting for revenue arising from contracts with customers (ASC 606 Revenue from Contracts with Customers). As a result of the adoption, there was no material impact to Ashland’s Consolidated Financial Statements. The additional disclosures that Ashland is required to disclose on an annual basis are contained within this Note R.

Ashland’s revenue is measured as the amount of consideration it expects to receive in exchange for transferring goods or providing services and is recognized when performance obligations are satisfied under the terms of contracts with customers. Ashland generally utilizes standardized language for the terms of contracts, unless a separate agreement has been entered into with a customer that supersedes the standard language.

A performance obligation is deemed to be satisfied by Ashland when control of the product or service is transferred to the customer. The transaction price of a contract, or the amount Ashland expects to receive upon satisfaction of all performance obligations, is determined by reference to the contract’s terms and includes adjustments, if applicable, for any variable consideration, such as volume discounts, rebates, refunds and rights to return. Where a contract contains more than one distinct performance obligation, the transaction price is allocated to each performance obligation based on the standalone selling price of each performance obligation, although these situations do not occur frequently and are generally not included within Ashland’s contracts. Any unsatisfied performance obligations were not material. Standalone selling prices are based on prices Ashland charges to customers, which in some cases are based on established market prices. Ashland generally collects the cash from its customers within 60 days of the product delivery date. Sales and other similar taxes collected from customers on behalf of third parties are excluded from the contract price.

All of Ashland’s revenue is derived from contracts with customers, and nearly all contracts with customers contain one performance obligation for the transfer of goods where such performance obligation is satisfied at a point in time. Control of a product is deemed to be transferred to the customer generally upon shipment or delivery. Costs for shipping and handling

activities, whether performed before or after the customer obtains control of the goods, are accounted for as fulfillment costs when not reimbursed.

Costs incurred to obtain contracts with customers have historically not been significant and are expensed immediately as the period of performance is generally one year or less. Ashland records bad debt expense in specific situations when it is determined that the customer is unable to meet its financial obligation.

Upon adoption, Ashland utilized the following applicable practical expedients, as permitted by ASC 606, Revenue from Contracts with Customers:

Trade receivables are defined as receivables arising from contracts with customers and are recorded within the accounts receivable caption within the Condensed Consolidated Balance Sheets. Ashland’s trade receivables were $435 million and $482 million as of September 30, 2019 and September 30, 2018, respectively.

Ashland disaggregates its revenue from contracts with customers by segment, geographical region and product category, as Ashland believes these categories best depict how management reviews the financial performance of its operations for the twelve months ended September 30, 2019, 2018 and 2017. Ashland includes only U.S. and Canada in its North America designation. See the following tables for details:

Sales by geography
(In millions)	Specialty Ingredients						Intermediates and Solvents
Geography	2019		2018		2017		2019		2018		2017
Twelve Months Ended
North America	$	945	$	988	$	883	$	58	$	58	$	34
Europe		779		806		683		23		24		21
Asia Pacific		458		454		432		25		31		32
Latin America & other		200		222		218		5		6		6
	$	2,382	$	2,470	$	2,216	$	111	$	119	$	93

Sales by product category
(In millions)	2019		2018		2017
Twelve Months Ended
Specialty Ingredients
Cellulosics	$	839	$	837	$	794
Poly-vinyl pyrrolidones		413		422		402
Adhesives		345		351		336
Actives		156		153		128
Vinyl ethers		106		139		139
Pharmachem		231		248		104
Other (a)		292		320		313
	$	2,382	$	2,470	$	2,216
Intermediates and Solvents
Derivatives	$	92	$	99	$	77
Butanediol		19		20		16
	$	111	$	119	$	93

Total	$	2,493	$	2,589	$	2,309